Chlorpromazine and dimethyl sulfoxide modulate the catalytic activity of the plasma membrane Ca2+-ATPase from human erythrocyte. 2018

Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
Laboratorio de Biología Molecular y Bioquímica (Edif. T-216), Departamento de Ciencias Químico-Biológicas, Instituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, C. P. 32310, Ciudad Juárez, CHI, Mexico. fplenge@uacj.mx.

The plasma membrane Ca2+-ATPase (PMCA) removes Ca2+ from the cytosol into the extracellular space. Its catalytic activity can be stimulated by calmodulin (CaM) or by limited proteolysis. We evaluated the effect of chlorpromazine (CPZ) and dimethyl sulfoxide (DMSO) over the hydrolytic activity of PMCA. Activity was monitored in three different forms: native, CaM-activated and proteolyzed by trypsin. CPZ appears to inhibit PMCA without directly interfering with the C-terminal site, since it is affected by CaM and proteolysis. Although the treatment of PMCA with trypsin and CaM produces an activation, it also produces an enzymatic form that is more sensitive to inhibition by CPZ. The same case was observed in the DMSO inhibition experiments. In the absence of CPZ, DMSO produces a progressive loss of activity, but in the presence of CPZ the profile of activity against DMSO changes and produces a recovery of activity, indicating a possible partition of CPZ by the solvent. Increasing Ca2+ concentrations indicated that CPZ interacts with PMCA rather than with CaM. This observation is supported by docking analysis that suggests that the CPZ-PMCA interaction is non-competitive. We propose that CPZ interacts with the state of lower affinity for Ca2 +.

UI MeSH Term Description Entries
D002147 Calmodulin A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium-Dependent Activator Protein,Calcium-Dependent Regulator,Bovine Activator Protein,Cyclic AMP-Phosphodiesterase Activator,Phosphodiesterase Activating Factor,Phosphodiesterase Activator Protein,Phosphodiesterase Protein Activator,Regulator, Calcium-Dependent,AMP-Phosphodiesterase Activator, Cyclic,Activating Factor, Phosphodiesterase,Activator Protein, Bovine,Activator Protein, Calcium-Dependent,Activator Protein, Phosphodiesterase,Activator, Cyclic AMP-Phosphodiesterase,Activator, Phosphodiesterase Protein,Calcium Dependent Activator Protein,Calcium Dependent Regulator,Cyclic AMP Phosphodiesterase Activator,Factor, Phosphodiesterase Activating,Protein Activator, Phosphodiesterase,Protein, Bovine Activator,Protein, Calcium-Dependent Activator,Protein, Phosphodiesterase Activator,Regulator, Calcium Dependent
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D053499 Plasma Membrane Calcium-Transporting ATPases Calcium-transporting ATPases found on the PLASMA MEMBRANE that catalyze the active transport of CALCIUM from the CYTOPLASM into the extracellular space. They play a role in maintaining a CALCIUM gradient across plasma membrane. Calcium-Transporting ATPases, Plasma Membrane,PMCA Calcium-Transporting ATPases,PMCA1 Calcium-Transporting ATPase,PMCA2 Calcium-Transporting ATPase,PMCA3 Calcium-Transporting ATPase,PMCA4 Calcium-Transporting ATPase,Plasma Membrane Ca(2+)-Pumping Adenosinetriphosphatase,Plasma Membrane Calcium ATPase,Plasma Membrane Calcium-Transporting ATPase 1,Plasma Membrane Calcium-Transporting ATPase 2,Plasma Membrane Calcium-Transporting ATPase 3,Plasma Membrane Calcium-Transporting ATPase 4,ATPase, PMCA1 Calcium-Transporting,ATPase, PMCA2 Calcium-Transporting,ATPase, PMCA3 Calcium-Transporting,ATPase, PMCA4 Calcium-Transporting,Calcium Transporting ATPases, Plasma Membrane,Calcium-Transporting ATPase, PMCA1,Calcium-Transporting ATPase, PMCA2,Calcium-Transporting ATPase, PMCA3,Calcium-Transporting ATPase, PMCA4,Calcium-Transporting ATPases, PMCA,PMCA Calcium Transporting ATPases,PMCA1 Calcium Transporting ATPase,PMCA2 Calcium Transporting ATPase,PMCA3 Calcium Transporting ATPase,PMCA4 Calcium Transporting ATPase,Plasma Membrane Calcium Transporting ATPase 1,Plasma Membrane Calcium Transporting ATPase 2,Plasma Membrane Calcium Transporting ATPase 3,Plasma Membrane Calcium Transporting ATPase 4,Plasma Membrane Calcium Transporting ATPases
D055162 Biocatalysis The facilitation of biochemical reactions with the aid of naturally occurring catalysts such as ENZYMES.
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
September 1998, Archives of biochemistry and biophysics,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
January 1981, General pharmacology,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
January 1986, Biochimica et biophysica acta,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
June 1985, Cell calcium,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
December 2005, Archives of biochemistry and biophysics,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
January 1999, Biochemical pharmacology,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
January 1989, Biochimica et biophysica acta,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
June 1986, Cell calcium,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
April 1985, Biochimica et biophysica acta,
Fernando Plenge-Tellechea, and Carlos A Domínguez-Solís, and Ángel G Díaz-Sánchez, and David Meléndez-Martínez, and Javier Vargas-Medrano, and Jorge A Sierra-Fonseca
November 1988, Archives of biochemistry and biophysics,
Copied contents to your clipboard!